Inhibition of fatty acid oxidation activates transforming growth factor-beta in cerebrospinal fluid and decreases spontaneous motor activity

Physiology and Behavior

Volumn 101, Issue 3, 2010, Pages 370-375

  Fujikawa, Teppei ^a,b   Fujita, Ryo ^a   Iwaki, Yoko ^a   Matsumura, Shigenobu ^a   Fushiki, Tohru ^a   Inoue, Kazuo ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

2 deoxyglucose; Exercise; Fatty acid oxidation; Mercaptoacetate; TGF beta; Vagotomy

Indexed keywords

DEOXYGLUCOSE; FATTY ACID; THIOGLYCOLIC ACID; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG ACTIVITY; ENERGY RESOURCE; EXERCISE; FATTY ACID OXIDATION; MALE; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RAT; VAGOTOMY; VAGUS NERVE;

ANALYSIS OF VARIANCE; ANIMALS; DEOXYGLUCOSE; ENERGY METABOLISM; ENZYME INHIBITORS; FATTY ACIDS; HOMEOSTASIS; MALE; MOTOR ACTIVITY; OXIDATION-REDUCTION; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; THIOGLYCOLATES; TRANSFORMING GROWTH FACTOR BETA; VAGUS NERVE;

EID: 77956177861     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2010.06.006     Document Type: Article

References (44)

1. Abe M., Harpel J.G., Metz C.N., Nunes I., Loskutoff D.J., Rifkin D.B. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 1994, 216:276-284.
2. Bartness T.J., Bamshad M. Innervation of mammalian white adipose tissue: implications for the regulation of total body fat. Am J Physiol 1998, 275:R1399-R1411.
3. Bauche F., Sabourault D., Giudicelli Y., Nordmann J., Nordmann R. Inhibition in vitro of acyl-CoA dehydrogenases by 2-mercaptoacetate in rat liver mitochondria. Biochem J 1983, 215:457-464.
4. Bottner M., Unsicker K., Suter-Crazzolara C. Expression of TGF-beta type II receptor mRNA in the CNS. NeuroReport 1996, 7:2903-2907.
5. Bottner M., Krieglstein K., Unsicker K. The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions. J Neurochem 2000, 75:2227-2240.
6. Boutellier S., Lutz T.A., Volkert M., Scharrer E. 2-Mercaptoacetate, an inhibitor of fatty acid oxidation, decreases the membrane potential in rat liver in vivo. Am J Physiol 1999, 277:R301-R305.
7. Brooks G.A., Mercier J. Balance of carbohydrate and lipid utilization during exercise: the "crossover" concept. J Appl Physiol 1994, 76:2253-2261.
8. Brouns F., van der Vusse G.J. Utilization of lipids during exercise in human subjects: metabolic and dietary constraints. Br J Nutr 1998, 79:117-128.
9. Brown P.D., Wakefield L.M., Levinson A.D., Sporn M.B. Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors 1990, 3:35-43.
10. Calingasan N.Y., Ritter S. Lateral parabrachial subnucleus lesions abolish feeding induced by mercaptoacetate but not by 2-deoxy-D-glucose. Am J Physiol 1993, 265:R1168-R1178.
11. Darling R.A., Ritter S. 2-Deoxy-D-glucose, but not mercaptoacetate, increases food intake in decerebrate rats. Am J Physiol Regul Integr Comp Physiol 2009, 297:R382-R386.
12. Friedberg S.J., Sher P.B., Bogdonoff M.D., Estes E.H. The dynamics of plasma free fatty acid metabolism during exercise. J Lipid Res 1963, 4:34-38.
13. Friedman M.I., Harris R.B., Ji H., Ramirez I., Tordoff M.G. Fatty acid oxidation affects food intake by altering hepatic energy status. Am J Physiol 1999, 276:R1046-R1053.
14. Fujikawa T., Matsumura S., Yamada H., Inoue K., Fushiki T. Transforming growth factor-beta in the brain enhances fat oxidation via noradrenergic neurons in the ventromedial and paraventricular hypothalamic nucleus. Brain Res 2007, 1173:92-101.
15. Hodgetts V., Coppack S.W., Frayn K.N., Hockaday T.D. Factors controlling fat mobilization from human subcutaneous adipose tissue during exercise. J Appl Physiol 1991, 71:445-451.
16. Hogberg H., Engblom L., Ekdahl A., Lidell V., Walum E., Alberts P. Temperature dependence of O2 consumption; opposite effects of leptin and etomoxir on respiratory quotient in mice. Obesity (Silver Spring) 2006, 14:673-682.
17. Holloway G.P., Bezaire V., Heigenhauser G.J., Tandon N.N., Glatz J.F., Luiken J.J.B., Bonen A., Spriet L.L. Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise. J Physiol 2006, 571:201-210. #35}.
18. Horn C.C., Ji H., Friedman M.I. Etomoxir, a fatty acid oxidation inhibitor, increases food intake and reduces hepatic energy status in rats. Physiol Behav 2004, 81:157-162.
19. Horowitz J.F., Klein S. Lipid metabolism during endurance exercise. Am J Clin Nutr 2000, 72:558S-563S.
20. Inoue K., Yamazaki H., Manabe Y., Fukuda C., Hanai K., Fushiki T. Transforming growth factor-beta activated during exercise in brain depresses spontaneous motor activity of animals. Relevance To central fatigue. Brain Res 1999, 846:145-153.
21. Ishikawa T., Mizunoya W., Shibakusa T., Inoue K., Fushiki T. Transforming growth factor-beta in the brain regulates fat metabolism during endurance exercise. Am J Physiol Endocrinol Metab 2006, 291:E1151-E1159.
22. Kondou H., Mushiake S., Etani Y., Miyoshi Y., Michigami T., Ozono K. A blocking peptide for transforming growth factor-beta1 activation prevents hepatic fibrosis in vivo. J Hepatol 2003, 39:742-748.
23. Langhans W., Scharrer E. Evidence for a vagally mediated satiety signal derived from hepatic fatty acid oxidation. J Auton Nerv Syst 1987, 18:13-18.
24. Li E.T., Anderson G.H. A role for vagus nerve in regulation of protein and carbohydrate intake. Am J Physiol 1984, 247:E815-E821.
25. Li M.X., Yoshida G., Horiuchi M., Kobayashi K., Saheki T. Prolonged effect of single carnitine administration on fasted carnitine-deficient JVS mice regarding their locomotor activity and energy expenditure. Biochim Biophys Acta 2006, 1761:1191-1199.
26. Lutz T.A., Diener M., Scharrer E. Intraportal mercaptoacetate infusion increases afferent activity in the common hepatic vagus branch of the rat. Am J Physiol 1997, 273:R442-R445.
27. Matsumura S., Shibakusa T., Fujikawa T., Yamada H., Inoue K., Fushiki T. Increase in transforming growth factor-beta in the brain during infection is related to fever, not depression of spontaneous motor activity. Neuroscience 2007, 144:1133-1140.
28. Matsumura S., Saitou K., Miyaki T., Yoneda T., Mizushige T., Eguchi A., et al. Mercaptoacetate inhibition of fatty acid beta-oxidation attenuates the oral acceptance of fat in BALB/c mice. Am J Physiol Regul Integr Comp Physiol 2008, 295:R82-R91.
29. Morton G.J., Cummings D.E., Baskin D.G., Barsh G.S., Schwartz M.W. Central nervous system control of food intake and body weight. Nature 2006, 443:289-295.
30. Ritter S., Taylor J.S. Vagal sensory neurons are required for lipoprivic but not glucoprivic feeding in rats. Am J Physiol 1990, 258:R1395-R1401.
31. Ritter S., Dinh T.T. 2-Mercaptoacetate and 2-deoxy-D-glucose induce Fos-like immunoreactivity in rat brain. Brain Res 1994, 641:111-120.
32. Ritter S., Hutton B. Mercaptoacetate-induced feeding is impaired by central nucleus of the amygdala lesions. Physiol Behav 1995, 58:1215-1220.
33. Romijn J.A., Coyle E.F., Sidossis L.S., Zhang X.J., Wolfe R.R. Relationship between fatty acid delivery and fatty acid oxidation during strenuous exercise. J Appl Physiol 1995, 79:1939-1945.
34. Rossi R., Geronimi M., Gloor P., Seebacher M.C., Scharrer E. Hyperpolarization of the cell membrane of mouse hepatocytes by fatty acid oxidation. Physiol Behav 1995, 57:509-514.
35. Scharrer E., Langhans W. Control of food intake by fatty acid oxidation. Am J Physiol 1986, 250:R1003-R1006.
36. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404:661-671.
37. Soya H., Mukai A., Deocaris C.C., Ohiwa N., Chang H., Nishijima T., et al. Threshold-like pattern of neuronal activation in the hypothalamus during treadmill running: establishment of a minimum running stress (MRS) rat model. Neurosci Res 2007, 58:341-348.
38. Torlinska T., Rutkowska D., Hryniewiecki T., Paluszak J. In vivo effect of 2-deoxy-D-glucose on adenine nucleotide levels in the liver and skeletal muscle of rats. Acta Physiol Pol 1990, 41:76-84.
39. Unsicker K., Flanders K.C., Cissel D.S., Lafyatis R., Sporn M.B. Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system. Neuroscience 1991, 44:613-625.
40. Uyama N., Geerts A., Reynaert H. Neural connections between the hypothalamus and the liver. Anat Rec A Discov Mol Cell Evol Biol 2004, 280:808-820.
41. Wick A.N., Drury D.R., Nakada H.I., Wolfe J.B. Localization of the primary metabolic block produced by 2-deoxyglucose. J Biol Chem 1957, 224:963-969.
42. Yamazaki H., Arai M., Matsumura S., Inoue K., Fushiki T. Intracranial administration of transforming growth factor-beta3 increases fat oxidation in rats. Am J Physiol Endocrinol Metab 2002, 283:E536-E544.
43. Yoshida G., Li M.X., Horiuchi M., Nakagawa S., Sakata M., Kuchiiwa S., et al. Fasting-induced reduction in locomotor activity and reduced response of orexin neurons in carnitine-deficient mice. Neurosci Res 2006, 55:78-86.
44. Yu Q., Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000, 14:163-176.